403 related articles for article (PubMed ID: 16625859)
1. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
5. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
6. The role of cortistatin in the human immune system.
van Hagen PM; Dalm VA; Staal F; Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):141-7. PubMed ID: 18450367
[TBL] [Abstract][Full Text] [Related]
7. Cortistatin - a new neuroendocrine hormone?
Rubinfeld H; Shimon I
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):106-10. PubMed ID: 17342027
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors in the thymus.
Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
10. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours.
Allia E; Tarabra E; Volante M; Cerrato M; Ghigo E; Muccioli G; Papotti M
J Pathol; 2005 Nov; 207(3):336-45. PubMed ID: 16161007
[TBL] [Abstract][Full Text] [Related]
11. [Somatostatin receptors in immune system cells].
Ferone D; Lombardi G; Colao A
Minerva Endocrinol; 2001 Sep; 26(3):165-73. PubMed ID: 11753240
[TBL] [Abstract][Full Text] [Related]
12. Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead.
Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Vázquez-Martínez R; Malagón MM; Castaño JP
Mol Cell Endocrinol; 2008 May; 286(1-2):128-34. PubMed ID: 18215456
[TBL] [Abstract][Full Text] [Related]
13. Physiology of somatostatin receptors.
Guillermet-Guibert J; Lahlou H; Cordelier P; Bousquet C; Pyronnet S; Susini C
J Endocrinol Invest; 2005; 28(11 Suppl International):5-9. PubMed ID: 16625838
[TBL] [Abstract][Full Text] [Related]
14. Brain-gut communication: cortistatin, somatostatin and ghrelin.
Broglio F; Papotti M; Muccioli G; Ghigo E
Trends Endocrinol Metab; 2007 Aug; 18(6):246-51. PubMed ID: 17632010
[TBL] [Abstract][Full Text] [Related]
15. The role of somatostatin and dopamine D2 receptors in endocrine tumors.
Gatto F; Hofland LJ
Endocr Relat Cancer; 2011 Dec; 18(6):R233-51. PubMed ID: 22135243
[TBL] [Abstract][Full Text] [Related]
16. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine aspects of immunolymphoproliferative diseases.
Ferone D; Hofland LJ; Colao A; Lamberts SW; van Hagen PM
Ann Oncol; 2001; 12 Suppl 2():S125-30. PubMed ID: 11762338
[TBL] [Abstract][Full Text] [Related]
19. Biology of somatostatin in breast cancer.
Watt HL; Kharmate G; Kumar U
Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]